Contact

Jamie Lacey-Moreira, PressComm PR Principal & Founder

Are you ready to give your communications strategy a new perspective? The PressComm PR team works with life science and health care organizations, delivering a flexible, resource-leveraging communications program.

Please contact Jamie to let us know how we can help your organization:

Jamie Lacey-Moreira, Principal
PressComm PR, LLC
Ph: 410.299.3310
Email: jamielacey@presscommpr.com

News

July 8, 2020

APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401
APEIRON to utilize MaxCyte’s ExPERT® platform for siRNA-based cell therapy APN401 targeting solid tumors and secures manufacturing for upcoming clinical trials VIENNA, AUSTRIA and GAITHERSBURG, [Read More]
June 30, 2020

Protaryx Medical Announces $8.3M in Funding for First-in-Class Technology for Left Atrial Access in Transcatheter Cardiac Procedures
$5.1M Series A Funding Led by Ajax Health Will Be Used to Develop First-in-Class Product Designed with Three-Dimensional, Independent Steerability to Deliver Reliable Access BALTIMORE--(BUSINESS [Read More]
June 30, 2020

BioBuzz: Former MedImmune Employees Leading In the BioHealth Capital Region and Beyond
In a recent conversation someone shared the quote “You can’t throw a stone in the BioHealth Capital Region and not hit somebody who worked at [Read More]

PressComm

Contact

Contact

Site Links

Social

About PressComm PR